Ignite Planners’s GSK GSK Stock Holding History

Ignite Planners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$668K	Sell	12,736 -211	-2%	-$11.2K	0.09%	219
2026 Q1	$712K	Sell	12,947 -618	-5%	-$33.5K	0.11%	188
2025 Q4	$700K	Sell	13,565 -7,458	-35%	-$348K	0.11%	189
2025 Q3	$907K	Sell	21,023 -1,048	-5%	-$40.9K	0.15%	147
2025 Q2	$801K	Buy	22,071 +2,018	+10%	+$77.1K	0.14%	153
2025 Q1	$777K	Buy	20,053 +1,088	+6%	+$39.8K	0.15%	147
2024 Q4	$635K	Buy	18,965 +1,210	+7%	+$43.6K	0.14%	140
2024 Q3	$726K	Buy	17,755 +851	+5%	+$34.8K	0.17%	124
2024 Q2	$657K	Sell	16,904 -64	-0.4%	-$2.69K	0.16%	133
2024 Q1	$720K	Sell	16,968 -8,116	-32%	-$335K	0.2%	113
2023 Q4	$941K	Sell	25,084 -2,462	-9%	-$88.4K	0.28%	92
2023 Q3	$996K	Buy	+27,546	New	+$978K	0.3%	84
2022 Q3	–	Sell	-4,650	Closed	-$252K	–	172
2022 Q2	$252K	Sell	4,650 -4,230	-48%	-$234K	0.21%	135
2022 Q1	$498K	Hold	8,880	–	–	0.33%	86
2021 Q4	$518K	Buy	+8,880	New	+$462K	0.34%	89

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ignite Planners's GSK Position: Q2 2026 in Review

Ignite Planners reduced its GSK (GSK) stake by 1.6% in Q2 2026, selling an estimated $11.2K and leaving 12,736 shares worth $668K. The position accounts for 0.09% of the portfolio, ranked #219.

Ignite Planners first reported a position in GSK in Q4 2021 and has held it in 15 quarters since. The position peaked at $996K in Q3 2023. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Ignite Planners held 12,736 shares of GSK worth $668K as of Q2 2026.
Ignite Planners sold 211 GSK shares in Q2 2026, an estimated $11.2K.
GSK made up 0.09% of Ignite Planners's portfolio in Q2 2026, its #219 holding.
Ignite Planners first reported a position in GSK in Q4 2021 and has held it in 15 quarters since.
Ignite Planners's GSK position peaked at $996K in Q3 2023.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.